These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23288576)

  • 1. The immune pathogenesis of scleroderma: context is everything.
    Greenblatt MB; Aliprantis AO
    Curr Rheumatol Rep; 2013 Jan; 15(1):297. PubMed ID: 23288576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis: current views of its pathogenesis.
    Derk CT; Jimenez SA
    Autoimmun Rev; 2003 Jun; 2(4):181-91. PubMed ID: 12848944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights on the role of the innate immune system in systemic sclerosis.
    York MR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple genes, especially immune-regulating genes, contribute to disease susceptibility in systemic sclerosis.
    Ma Y; Zhou X
    Curr Opin Rheumatol; 2016 Nov; 28(6):595-605. PubMed ID: 27533323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models in systemic sclerosis.
    Rogai V; Lories RJ; Guiducci S; Luyten FP; Matucci Cerinic M
    Clin Exp Rheumatol; 2008; 26(5):941-6. PubMed ID: 19032835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?
    Assassi S; Mayes MD
    Curr Opin Rheumatol; 2013 Nov; 25(6):686-91. PubMed ID: 24061076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
    Kuzumi A; Yoshizaki A; Matsuda KM; Kotani H; Norimatsu Y; Fukayama M; Ebata S; Fukasawa T; Yoshizaki-Ogawa A; Asano Y; Morikawa K; Kazoe Y; Mawatari K; Kitamori T; Sato S
    Nat Commun; 2021 Oct; 12(1):5947. PubMed ID: 34642338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts.
    Zhou X; Tan FK; Xiong M; Milewicz DM; Feghali CA; Fritzler MJ; Reveille JD; Arnett FC
    J Immunol; 2001 Dec; 167(12):7126-33. PubMed ID: 11739535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.
    Yang H; Cheong S; He Y; Lu F
    Stem Cell Res Ther; 2023 Dec; 14(1):372. PubMed ID: 38111001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.
    Tsujino K; Sheppard D
    Curr Rheumatol Rep; 2016 Jan; 18(1):4. PubMed ID: 26711695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors.
    Maria ATJ; Partouche L; Goulabchand R; Rivière S; Rozier P; Bourgier C; Le Quellec A; Morel J; Noël D; Guilpain P
    Front Immunol; 2018; 9():3112. PubMed ID: 30687318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.
    Bujor AM; El Adili F; Parvez A; Marden G; Trojanowska M
    Front Immunol; 2020; 11():800. PubMed ID: 32508810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
    Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
    Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of systemic sclerosis: prospects and limitations.
    Beyer C; Schett G; Distler O; Distler JH
    Arthritis Rheum; 2010 Oct; 62(10):2831-44. PubMed ID: 20617524
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic abnormalities in scleroderma.
    Amento EP
    Semin Cutan Med Surg; 1998 Mar; 17(1):18-21. PubMed ID: 9512102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models in systemic sclerosis: an update.
    Bi X; Mills T; Wu M
    Curr Opin Rheumatol; 2023 Nov; 35(6):364-370. PubMed ID: 37605874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
    Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
    J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.